Mackay Shields LLC’s Regenxbio RGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-42,057
Closed -$1.43M 1192
2021
Q1
$1.43M Sell
42,057
-26,812
-39% -$1.14M 0.01% 895
2020
Q4
$3.12M Buy
68,869
+3,700
+6% +$129K 0.02% 651
2020
Q3
$1.79M Buy
65,169
+19,200
+42% +$626K 0.01% 835
2020
Q2
$1.69M Buy
45,969
+13,600
+42% +$507K 0.01% 832
2020
Q1
$1.05M Buy
32,369
+3,500
+12% +$146K 0.01% 931
2019
Q4
$1.18M Sell
28,869
-6,500
-18% -$257K 0.01% 1034
2019
Q3
$1.26M Buy
35,369
+6,700
+23% +$271K 0.01% 1059
2019
Q2
$1.47M Buy
28,669
+17,712
+162% +$884K 0.01% 1017
2019
Q1
$628K Buy
10,957
+1,100
+11% +$54.5K ﹤0.01% 1126
2018
Q4
$414K Sell
9,857
-1,043
-10% -$61.2K ﹤0.01% 1197
2018
Q3
$823K Sell
10,900
-600
-5% -$43.2K 0.01% 923
2018
Q2
$825K Buy
+11,500
New +$549K 0.01% 1006

Other funds holding RGNX